Status | Finished |
---|
Effective start/end date | 1/09/2017 → 31/08/2023 |
---|
- King's College London
- Karolinska Institute (Collaborating partner) (lead)
- Deutsches Rheuma-Forschungszentrum (Collaborating partner)
- Medical University of Vienna (Collaborating partner)
- University of Birmingham (Collaborating partner)
- Universitätsklinikum Erlangen (Collaborating partner)
- Newcastle University (Collaborating partner)
- University of Glasgow (Collaborating partner)
- LUMC Leiden University Medical Center (Collaborating partner)
- University of Queensland (Collaborating partner)
- Semmelweis University
- Apitope International NV
- Anocca AB
- Institute for Research in Biomedicine
- Janssen Pharmaceutica N.V.
- UCB Pharma S.A.
- GSK GlaxoSmithKline Research & Development Ltd
- Sanofi S.A.
- Bristol-Myers Squibb Company
- Pfizer Ltd
- EC European Commission: £4,380,000.00